W81K0224F0134

FDA APPROVED REAGENTS AND CONTROLS WITH SYSMEX XN9100-201 SYSTEM W/ CELLAVISION DI-60 FOR DEPT. OF PATHOLOGY, TAMC

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Defense
Office	W40M MRCO PACIFIC
NAICS	334516 — Analytical Laboratory Instrument Manufacturing
PSC	6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Parent award / vehicle	V797D40235
Set-aside	Not reported
Pricing type	FIRM FIXED PRICE
Obligations	$110.2K
Current contract value	$110.2K
Potential contract value / ceiling	$110.2K
Start date	Oct 1, 2024
Current end date	Sep 30, 2025
Potential end date	Sep 30, 2025
Latest award activity	Feb 25, 2026
Source loaded	Sep 19, 2026

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Feb 25, 2026	P00004	$-5.7K	FDA APPROVED REAGENTS AND CONTROLS WITH SYSMEX XN9100-201 SYSTEM WITH CELLAVISION DI-60 FOR DEPT OF PATHOLOGY, TRIPLER ARMY MEDICAL CENTER, HI. MOD P00003: EXERCISE OPTION 1 (1 OCT 2025 - 30 SEP 2026)
Aug 20, 2025	P00003	$0	FDA APPROVED REAGENTS AND CONTROLS WITH SYSMEX XN9100-201 SYSTEM WITH CELLAVISION DI-60 FOR DEPT OF PATHOLOGY, TRIPLER ARMY MEDICAL CENTER, HI. MOD P00003: EXERCISE OPTION 1 (1 OCT 2025 - 30 SEP 2026)
Aug 5, 2025	P00002	$-121.7K	FOOD AND DRUG ADMINISTRATION APPROVED REAGENTS AND CONTROLS WITH SYSMEX XN9100-201 SYSTEM WITH CELLAVISION DI-60 FOR DEPT OF PATHOLOGY, TRIPLER ARMY MEDICAL CENTER, HI. MODIFICATION P00002: DEOBLIGATE UNUSED FY25 FUNDS.
Oct 17, 2024	P00001	$237.6K	SYSMEX HEMATOLOGY REAGENTS & CONTROLS W/ USE OF SYSMEX XN9100-201 SYSTEM WITH CELLAVISION DI-60. BASE PERIOD: 1 OCT 2024 - 30 SEP 2025. INCORPORATE FY25 FUNDS AND QUOTE NO. 49275.